Prime editing enables drug-controllable T-cell therapies with clinical immunosuppression
Blood
· Elsevier
The publisher did not provide an abstract — full text is available via the link below.
Read at publisher →
Citation
Prime editing enables drug-controllable T-cell therapies with clinical immunosuppression. // Blood. – URL: https://www.sciencedirect.com/science/article/pii/S0006497126017684?dgcid=rss_sd_all
Prime editing enables drug-controllable T-cell therapies with clinical immunosuppression. Blood. https://www.sciencedirect.com/science/article/pii/S0006497126017684?dgcid=rss_sd_all
“Prime editing enables drug-controllable T-cell therapies with clinical immunosuppression.” Blood.
@article{article38293,
title = {Prime editing enables drug-controllable T-cell therapies with clinical immunosuppression},
journal = {Blood},
url = {https://www.sciencedirect.com/science/article/pii/S0006497126017684?dgcid=rss_sd_all}
}